Jane Street’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Buy |
7,718,265
+7,588,902
| +5,866% | +$20M | ﹤0.01% | 507 |
|
|
2025
Q1 | $389K | Sell |
129,363
-122,712
| -49% | -$369K | ﹤0.01% | 4253 |
|
|
2024
Q4 | $645K | Buy |
252,075
+156,466
| +164% | +$401K | ﹤0.01% | 3562 |
|
|
2024
Q3 | $356K | Sell |
95,609
-1,620,450
| -94% | -$6.03M | ﹤0.01% | 4692 |
|
|
2024
Q2 | $10.8M | Buy |
1,716,059
+1,407,921
| +457% | +$8.9M | ﹤0.01% | 1013 |
|
|
2024
Q1 | $1.65M | Sell |
308,138
-513,505
| -62% | -$2.76M | ﹤0.01% | 2562 |
|
|
2023
Q4 | $4.12M | Buy |
+821,643
| New | +$4.12M | ﹤0.01% | 1691 |
|
|
2023
Q3 | – | Sell |
-146,732
| Closed | -$408K | – | 5379 |
|
|
2023
Q2 | $408K | Sell |
146,732
-78,024
| -35% | -$217K | ﹤0.01% | 3948 |
|
|
2023
Q1 | $409K | Buy |
224,756
+177,896
| +380% | +$324K | ﹤0.01% | 3892 |
|
|
2022
Q4 | $238K | Buy |
46,860
+27,986
| +148% | +$142K | ﹤0.01% | 4221 |
|
|
2022
Q3 | $94K | Sell |
18,874
-23,731
| -56% | -$118K | ﹤0.01% | 4918 |
|
|
2022
Q2 | $159K | Sell |
42,605
-107,001
| -72% | -$399K | ﹤0.01% | 4570 |
|
|
2022
Q1 | $840K | Buy |
149,606
+122,403
| +450% | +$687K | ﹤0.01% | 3160 |
|
|
2021
Q4 | $165K | Buy |
27,203
+15,145
| +126% | +$91.9K | ﹤0.01% | 4482 |
|
|
2021
Q3 | $118K | Sell |
12,058
-17,990
| -60% | -$176K | ﹤0.01% | 4635 |
|
|
2021
Q2 | $429K | Sell |
30,048
-12,528
| -29% | -$179K | ﹤0.01% | 3583 |
|
|
2021
Q1 | $1.01M | Sell |
42,576
-30,265
| -42% | -$719K | ﹤0.01% | 2496 |
|
|
2020
Q4 | $971K | Buy |
72,841
+35,041
| +93% | +$467K | ﹤0.01% | 2138 |
|
|
2020
Q3 | $262K | Sell |
37,800
-26,853
| -42% | -$186K | ﹤0.01% | 2991 |
|
|
2020
Q2 | $794K | Buy |
+64,653
| New | +$794K | ﹤0.01% | 2145 |
|
|
2019
Q3 | – | Sell |
-89,914
| Closed | -$92K | – | 3676 |
|
|
2019
Q2 | $92K | Buy |
+89,914
| New | +$92K | ﹤0.01% | 3293 |
|